Academic Journal
Development and evaluation of an e-learning program on drug-related problems for community pharmacists.
| Τίτλος: | Development and evaluation of an e-learning program on drug-related problems for community pharmacists. |
|---|---|
| Συγγραφείς: | Vogt CJ; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Reuther A; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Wurmbach VS; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Weißenborn M; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Bittmann JA; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Wien K; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Lampert A; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Eknes EMB; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Centre for Pharmacy, University Bergen, Bergen, Norway., Schäfer P; Chamber of Pharmacists Baden-Wurttemberg, Stuttgart, Germany., Seidling HM; Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX-Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. Hanna.seidling@med.uni-heidelberg.de. |
| Πηγή: | International journal of clinical pharmacy [Int J Clin Pharm] 2026 Aug; Vol. 48 (4), pp. 1349-1358. Date of Electronic Publication: 2026 Mar 25. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Dordrecht : Springer |
| Ιατρικοί όροι (MeSH): | Pharmacists*/standards , Community Pharmacy Services*/standards , Education, Pharmacy, Continuing*/methods , Drug-Related Side Effects and Adverse Reactions*/diagnosis , Drug-Related Side Effects and Adverse Reactions*/prevention & control , Computer-Assisted Instruction*/methods , Computer-Assisted Instruction*/standards , Program Evaluation*/methods , Program Development*/methods , Program Development*/standards, Humans ; Female ; Male ; Adult |
| Περίληψη: | Introduction: Community pharmacists (CPs) are pivotal in the management of drug-related problems (DRPs), yet a need for additional training has been recognized. Aim: The aim was to develop and evaluate an e-learning program to enhance pharmacists' ability to detect and manage DRPs. Method: The e-learning program provided a self-paced learning experience with 10 modules, each focusing on a DRP. The DRPs were chosen as part of a previous Delphi consensus study. The development team, consisting of researchers, clinical pharmacists, and CPs, considered DRPs applicable if they occurred frequently and could be solved in a pharmacy. Moreover, a predefined checklist was established to guide the development of new modules and specify quality standards. Each module was structured into an educational phase (tutorials, pre- and post-knowledge quizzes, in-depth exercises), and a practical phase (documentation of anonymized patient encounters). After completing all modules, participants took a final comprehensive quiz with 2 questions per module (in total 20 questions). The program was evaluated on multiple levels: pharmacists' knowledge change, how they implemented this knowledge in practice, and their feedback. Data were analyzed descriptively. Comparison between the quizzes were calculated using the Wilcoxon test. Results: A total of 203 pharmacists registered to participate in the study, with participation declining across modules (184 participants completed Module 1 pre-knowledge quiz vs. 119 in Module 10). Across all modules, a significant knowledge increase was observed when comparing pre- and post-knowledge-quizzes (p < 0.001). Knowledge levels remained high in the final quiz (on average 1.63 ± 0.61 correct answers). Participants documented 13,778 patient encounters, thereof 5073 encounters with at least one DRP. According to the participants, most of the DRPs (90.1%, n = 4550) could be resolved. A total of 1137 feedbacks were received. Overall, feedback was positive, with participants highlighting improved abilities to engage with patients (85.2%, n = 969) and to identify DRPs (82.0%, n = 629). Conclusion: By bridging the gap between theoretical learning and practical application, this e-learning program improves pharmacists' skills in DRP management. (© 2026. The Author(s).) |
| Competing Interests: | Declarations. Competing interest: This work was financially supported by the Baden-Württemberg Chamber of Pharmacists (Germany). There are no other conflicts of interest regarding this work. Outside of the submitted work, Cathrin J. Vogt, Viktoria S. Wurmbach and Janina A. Bittmann received honoraria for lectures from the Landesapothekerkammer Baden-Württemberg (Chamber of Pharmacists in Baden-Württemberg). Patrick Schäfer received honoraria for being the author and editor of the book ‘Allgemeinpharmazie’. Hanna M. Seidling reports relationships with several research funds related to medication safety (e.g. G-BA Innovationsfonds, BMG, BMBF, BfArM, Förderinitiative Pharmazeutische Betreuung), including ongoing support for the eLearning programme (Chamber of Pharmacists, Baden-Württemberg). She also reports receiving honoraria for lectures and book chapters, travel reimbursements for congresses or meetings related to medication safety from professional organisations and publishing companies, and board membership of several organisations. Consent for participate: All participants consented to participate in the study while registering to the program. Consent to publish: N/a. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was obtained from the Medical Faculty of the University Hospital Heidelberg, with approval reference number S-607/2016. |
| References: | Ann Pharmacother. 2011 Sep;45(9):1067-76. (PMID: 21878658) Am J Pharm Educ. 2022 Apr;86(4):8633. (PMID: 34400397) Drugs Aging. 2020 Feb;37(2):115-123. (PMID: 31782128) Am J Pharm Educ. 2019 Oct;83(8):6874. (PMID: 31831890) Front Pharmacol. 2021 Aug 17;12:698907. (PMID: 34489695) Int J Pharm Pract. 2012 Aug;20(4):238-48. (PMID: 22775520) J Am Pharm Assoc (2003). 2026 Jan-Feb;66(1):102962. (PMID: 41173320) J Am Pharm Assoc (2003). 2025 Sep-Oct;65(5):102418. (PMID: 40349977) Pharm World Sci. 2008 Dec;30(6):924-33. (PMID: 18802782) Res Social Adm Pharm. 2017 Nov;13(6):1127-1134. (PMID: 27816566) Int J Clin Pharm. 2016 Oct;38(5):1080-6. (PMID: 27329381) Int J Clin Pharm. 2020 Apr;42(2):588-597. (PMID: 32026355) Int J Clin Pharm. 2018 Oct;40(5):1317-1327. (PMID: 30099664) Int J Clin Pract. 2021 Nov;75(11):e14864. (PMID: 34523204) Res Social Adm Pharm. 2024 Aug;20(8):679-688. (PMID: 38811260) BMC Med Educ. 2014 Feb 15;14:33. (PMID: 24528547) Int J Clin Pharm. 2017 Dec;39(6):1171-1174. (PMID: 29038935) Glob Health Res Policy. 2023 Jul 12;8(1):25. (PMID: 37434230) Med Care. 1993 May;31(5):451-68. (PMID: 8501992) PLoS One. 2022 May 4;17(5):e0267379. (PMID: 35507568) Res Social Adm Pharm. 2021 Mar;17(3):488-496. (PMID: 32381423) Ann Pharmacother. 2004 May;38(5):859-67. (PMID: 15054145) Int J Clin Pharm. 2025 Apr;47(2):247-269. (PMID: 39775382) Int J Pharm Pract. 2016 Feb;24(1):60-71. (PMID: 26173959) Int J Clin Pharm. 2021 Jun;43(3):726-730. (PMID: 33025450) Int J Clin Pharm. 2024 Aug;46(4):987-991. (PMID: 38704778) Innov Pharm. 2021 Feb 11;12(1):. (PMID: 34007683) J Am Geriatr Soc. 2018 Aug;66(8):1613-1620. (PMID: 29972691) Am J Pharm Educ. 2023 Aug;87(8):100003. (PMID: 37597909) Age Ageing. 2023 Feb 1;52(2):. (PMID: 36821644) BMJ Open. 2020 Jun 1;10(6):e034674. (PMID: 32487573) J Clin Pharm Ther. 2014 Jun;39(3):248-52. (PMID: 24521180) Eur J Pharmacol. 2025 Nov 5;1006:178124. (PMID: 40930483) Am J Pharm Educ. 2016 Jun 25;80(5):88. (PMID: 27402991) Acad Med. 2022 May 1;97(5):689-695. (PMID: 35171122) Am J Pharm Educ. 2014 May 15;78(4):83. (PMID: 24850945) |
| Contributed Indexing: | Keywords: Community pharmacy; Continuing education; Drug-related problems; e-learning |
| Entry Date(s): | Date Created: 20260325 Date Completed: 20260714 Latest Revision: 20260813 |
| Update Code: | 20260813 |
| PubMed Central ID: | PMC13369537 |
| DOI: | 10.1007/s11096-026-02111-5 |
| PMID: | 41879925 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 2210-7711 |
|---|---|
| DOI: | 10.1007/s11096-026-02111-5 |